Abstract

Survival prospects in adults with congenital heart disease (CHD), although improved in recent decades, still remain below expectations for the general population. Patients and their loved ones benefit from preparation for both unexpected and predictable deaths, sometimes preceded by a prolonged period of declining health. Hence, advance care planning (ACP) is an integral part of comprehensive care for adults with CHD. This position paper summarizes evidence regarding benefits of and patients’ preferences for ACP and provides practical advice regarding the implementation of ACP processes within clinical adult CHD practice. We suggest that ACP be delivered as a structured process across different stages, with content dependent upon the anticipated disease progression. We acknowledge potential barriers to initiate ACP discussions and emphasize the importance of a sensitive and situation-specific communication style. Conclusions presented in this article reflect agreed expert opinions and include both patient and provider perspectives.

Introduction

Advances in the diagnosis and treatment of congenital heart defects over the past few decades have led to unparalleled changes in the patient demographic profile, such that adults now outnumber children with congenital heart disease (CHD).1 Improved survival has been driven largely by a reduction in infant mortality, particularly among individuals born with severe forms of CHD.2 With decreasing mortality in the young, the CHD population is not only growing but also aging. The prevalence of adults with CHD older than 60 years increased 10-fold from 2000 to 2013 and is currently estimated at 5–10% of the entire CHD population.3  ,  4 Many now live long enough to acquire typical age-related comorbidities.5 Over 50% of a contemporary adult CHD (ACHD) cohort receiving follow-up at a tertiary centre had at least one acquired comorbidity and almost a quarter had two or more comorbidities.6 Although survival beyond the age of 18 years is now >90%,7 survival prospects for adults with CHD still remain below expectations for the general population.8  ,  9 The most common cause of death among young people living with CHD is sudden cardiac death, while heart failure supersedes it in the aging CHD population.10 Therefore, we should prepare adults with CHD and their families for both unexpected and predictable deaths, sometimes preceded by a prolonged period of declining health.

The aims of this position paper are to summarize current evidence regarding benefits of and patients’ preferences for advance care planning (ACP) and to provide practical advice regarding the implementation of ACP processes within clinical ACHD practice. Adult congenital heart disease healthcare providers require skills facilitating the timely and sensitive initiation of ACP and the co-ordination of holistic care for adults with CHD at all stages of their life.11  ,  12 Conclusions presented in this paper are agreed expert recommendations of general rules extrapolated from the ACHD population12 and also other adults with cardiovascular disease. This position paper includes both patient and provider perspectives and contributions. Box 1 summarizes the patient perspective in the words of a representative living with CHD.

Box 1 The perspective of adults living with congenital heart disease
  • In a society that mutes discussions on death and dying and that simplistically lauds improved adult congenital heart disease (ACHD) outcomes as success stories, healthcare providers tend to avoid and/or delay advance care planning (ACP) discussions with their patients.

  • Patient organizations can help healthcare providers spread information about ACP. They are also irreplaceable for adults with congenital heart disease (CHD) to have conversations about ACP among peers.

  • Documents for ACP available on the Internet through various organizations are usually tailored to elderly people and not to adults with CHD. Adults with CHD would benefit from assistance when using such documents.

  • Discussions with healthcare providers about future health are typically welcome, even though this is often considered a stressful topic. Adults with CHD and ACHD healthcare professionals may be challenged by the art of finding the right words at the right moment.

  • When an adult with CHD asks what can be done for them, the answer should be realistic and may include comfort measures rather than (or in addition to) strategies to extend life: ‘all that can be done when nothing more can be done’.

  • Many individuals have clear ideas about what they consider the worst possible way to die. It is helpful to discuss strategies for preventing such dreaded situations.

  • Hope is not just about medical outcomes. Rather than lingering in discomfort, adults with CHD may hope for a sudden death, for effective comfort measures, and for emotional, spiritual, and interpersonal support during the last chapters of their biography.

Terminology and concepts related to advance care planning

A definition of ACP is provided in Box 2—glossary of terms. Advance care planning is based upon consideration of situations that might arise in the future in a person’s life.13  ,  14 Advance care planning helpfully begins with identifying personal values and goals in an effort to align future medical treatment and care with these convictions. Knowledge of a person’s personality and her or his social supports may be helpful for tailoring discussions. The process can be presented to patients and families as ‘preparing for the worst, while hoping for the best’.15 During this reflective process a person may decide which treatments and care measures she or he would prefer in specific situations. Achieving the best possible quality of life within the context of advanced heart disease may entail timely involvement of palliative care (see Box 2—glossary of terms), of which key elements include symptom relief, psychosocial support, and spiritual care.16 There are existing position papers and reviews related to the delivery of palliative care in heart disease patients.17  ,  18 The primary focus of this position paper is the extended process of ACP rather than palliative or end-of-life care.

Box 2 Advance care planning: glossary of terms

Advance care planning is a process that supports and empowers individuals, at any stage of their lives or the disease process, to consider, communicate, and document preferences for future health care to their loved ones and healthcare providers. During this process, individuals have the opportunity to make decisions in advance about treatment they would and would not want should they be unable to express their wishes at that time. This process benefits (i) patients (by increasing the likelihood that their wishes will be followed), (ii) loved ones (by helping them more confidently express patients’ wishes if necessary), and (iii) healthcare providers (by providing information sufficient to align treatment plans with patient goals and preferences).

Advance directives are paper and/or electronic documents that specify a person’s preferences and decisions (including the naming of a healthcare representative) for medical treatments or care in advance of a potential serious medical event/situation when they may be unable to communicate this information. Specific documentation requirements may vary depending upon where a patient lives.

A healthcare representative (also referred to as a substitute decision maker, surrogate decision maker, power of attorney for personal care or healthcare proxy) is a named individual that a person entrusts to express their wishes and make medical decisions on their behalf should the individual be unable to speak for themselves.

Palliative care has traditionally referred to care focused on alleviating symptoms and enhancing quality of life and quality of the dying experience rather than curing disease or extending life. The modern definition has been expanded to describe comprehensive care that addresses the physical, psychosocial, and spiritual needs of individuals with diseases unresponsive to curative treatments. Such care is ideally introduced early in the course of the illness and meets the needs of patients and their loved ones.

Physician Orders for Life-Sustaining Treatment (POLST) are medical orders to be honoured by healthcare workers during a critical event. Unlike advance directives, POLST document the patients’ wishes in the form of binding orders (i.e. no referral to the intensive care unit) but do not include other more general preferences such as identifying a healthcare representative.

Benefits of advance care planning for people with advanced cardiovascular disease

The American Heart Association,19 the European Society of Cardiology,20  ,  21 and the European Association for Palliative Care17 recommend ACP for people with advanced cardiac disease, including those with heart failure. Advance care planning would ideally become a routine part of heart failure care, reviewed annually and more often as needed in accordance with disease progression. Benefits of timely initiation of an ACP process are summarized in Figure 1. Despite a limited quantitative and qualitative evidence base, ACP is considered as a marker of excellent care in advanced chronic heart failure.22 Advance care planning is also indicated for ACHD patients with advanced cardiac disease. However, the disease trajectory, patient characteristics, and social situation may differ substantially in ACHD compared to acquired heart failure. Specific recommendations for adults with CHD directed the preparation of this document.

The advance care planning process benefits not only the individual but also their loved ones and care providers.56–  63 Societal discussions of quality vs. quantity of life as well as limitations of care are also important.
Figure 1

The advance care planning process benefits not only the individual but also their loved ones and care providers.56–  63 Societal discussions of quality vs. quantity of life as well as limitations of care are also important.

Advance care planning needs and preferences among adults with congenital heart disease

  • For adults with CHD, the following empirical findings regarding ACP experiences and preferences have been reported:23–27

  • Discussions about ACP occur infrequently in routine ACHD outpatient visits.

  • Most healthcare providers report that they reserve discussions about ACP for adults living with complex defects and/or at advanced stages of their condition.

  • The majority of adults with CHD report interest in ACP independent of underlying defect severity and prefer that such discussions be initiated early in the disease course, before life-threatening complications occur. In one study, 18 years of age was identified as the most appropriate age to initiate an ACP dialogue.26

  • Although most adults with CHD report interest in ACP and in receiving information about the general life expectancy of individuals with their type of CHD, some prefer not to have such conversations.

  • Although the majority of adults with CHD favour having an advance directive (see Box 2—glossary of terms) available if they are unable to speak for themselves, few have previously completed advance directives or appointed a healthcare representative.

  • Most adults with CHD would prefer to have discussions about ACP care with their treating ACHD physician. The trusting relationship between a patient and their ACHD physician was identified as a facilitator for the initiation of such discussions.

  • Factors associated with greater interest in ACP discussions include being married, perceiving a shorter lifespan compared to peers, and having more pronounced anxiety symptoms.

Implementation of advance care planning within clinical adult congenital heart disease practice

Initiation of advance care planning process

The process of ACP may be initiated at any moment in life, independent of a person’s health status, and ACP should thus be addressed with all adults with CHD at some time in their lives.11 Although tools like the ‘surprise question’ posed to healthcare providers (i.e. ‘Would you be surprised if this person died in the next year?’) are not validated as prognostic markers in adults with CHD, they can help identify individuals who may benefit from deliberate and thoughtful reflection regarding future health expectations.28 Furthermore, the circumstances below might prompt the initiation of ACP discussions and review of previously expressed ACP preferences and documents as appropriate (see also Supplementary material online, Table S1).14  ,  29  ,  30

Disease progression and worsening prognosis are milestones in the disease course that may initiate the process of ACP in a way that seems most natural.31Population-based prognoses can be estimated using generic32  ,  33 or CHD-specific tools. Although estimating prognoses in individuals with CHD remains challenging due to less predictable disease trajectories, certain CHD diagnoses have been associated with markedly reduced life expectancy, such as Fontan circulation, a systemic right ventricle, and cyanotic heart disease. For example, the estimated 5-year mortality of a 40-year-old person with Fontan physiology is comparable to that of a 75-year-old person from the general population.34 Many individuals with complex CHD are unaware of their prognosis and overestimate their life expectancy, which may result in requests or expectations that are at odds with experienced clinical judgement.15 Exploration of these inconsistencies may naturally trigger ACP.

A second opportunity to initiate ACP occurs at the time of consideration of interventions including cardiac surgery, complex catheter-based therapeutic interventions, implantable cardioverter defibrillator (ICD) implantation, ventricular assist device implantation, or heart transplantation. A ‘what if?’ dialogue can be incorporated into the discussion of potential complications threatening survival, independent functioning or decision-making capacity.30 During such dialogue, the option of declining the proposed treatment or intervention if incompatible with personal goals and alternative management options should be presented. The discussion can be expanded to include longer-term health expectations in addition to potential immediate complications of the intervention. The occurrence of an acute event (e.g. acute heart failure, ventricular arrhythmia requiring cardioversion) or any other unplanned hospital admission can also trigger the reflective process of ACP. If not relevant or possible early in the course of a hospitalization, ACP can be initiated before discharge by exploring patient’s wishes should another acute event occur.30

Changes in a person’s social system, such as death of a close family member, death of an ACHD peer, and family planning, may trigger ACP due to acute awareness of mortality.35  ,  36 As part of the pre-pregnancy counselling process,37 the impact of pregnancy on long-term functioning and future health can lead directly to a comprehensive discussion of ACP.38

Advance care planning discussions should not be restricted to adults of a certain age group and can also be appropriate for adolescents and young adults with CHD.39  ,  40 Discussion of the impact of CHD on later life and anticipated long-term outcomes can be an integral part of the transition process from paediatric to adult care,41 particularly for patients with complex defects. As with patients of all ages, the potential emotional impact for patients and their families must be acknowledged.

Overcoming barriers to the advance care planning process

Table 1 presents known barriers that may hamper the initiation of the ACP process as well as proposed solutions. Advance care planning has become a frequent theme in ACHD peer groups and patient organizations, highlighting that people with CHD are increasingly identifying this as an important topic of discussion. As such, ACHD programmes are encouraged to partner with national or international patient organizations (e.g. www.echdo.eu, www.global-arch.org, www.achaheart.org) to provide educational ACP activities, such as webinars. Some patients may appreciate an introduction to ACP concepts in this more general forum prior to having personal discussions in the clinical setting.

Table 1

Barriers to advance care planning communication and proposed clinical strategies

BarrierStrategies for healthcare providers
At patient level
 No/minimal knowledge about ACPProvide education about the rationale for ACP
 Reluctance to begin this discussion
  • Introduce and normalize this topic in broader terms during a routine clinic visit and offer the opportunity to discuss in more detail at a follow-up visit

  • Encourage patients to have loved ones present for these conversations

  • Introduce ACP during situations when it seems to occur more naturally (e.g. death of a close family member or an ACHD peer, family planning, prior to cardiac intervention)

 Avoidance of discussion of health deterioration (which might be amplified during acute cardiac events)Initiate ACP during stable (rather than acute) phase of the disease to allow for a less-pressured patient experience
 Desire to protect family and loved onesEducate about the advantages of ACP communication and advance directives for family members should they be faced making treatment or care decisions for the patient in the future
At healthcare provider level
 Fear of causing patients to experience unnecessary emotional distress
  • Acknowledge that emotional reactions to disappointing information are understandable

  • Acknowledge and label emotional reactions as they occur

  • Strive for a balance between preparation for undesired outcomes and maintaining hope; emphasize that these are not mutually exclusive

  • Emphasize that ACP is intended to be an empowering process for patients and their loved ones

 Uncertainty about prognosis
  • Acknowledge challenges associated with an unpredictable disease trajectory

  • Use standardized prognostic indexes (e.g. NYHA class) or results from functional testing (e.g. cardiopulmonary exercise testing) to guide predictions

  • Offer broader time ranges for life expectancy (i.e. decades vs. years vs. months vs. weeks)

 Lack of confidence and skills in ACP
  • Practice discussions with colleagues to develop comfort with this language

  • Consider a standardized approach (e.g. ask-tell-ask) to initiate discussions

  • Use a checklist to guide discussions (see Supplementary material online)

  • Seek continuing education opportunities

  • Liaise with a palliative care team to enhance skills

 Low familiarity with specific patient factors that warrant unique attention (e.g. culture, religion, background)
  • Communicate in a respectful and sensitive manner

  • Inquire about religious, cultural and background factors that may impact patients’ decision-making

  • Maintain a respectful curiosity regarding patients’ beliefs and practices

  • Avoid assumptions based on patients’ culture, religion, or background

 Personal discomfort with ACP discussions and end-of-life care
  • Acknowledge that emotional reactions are understandable

  • Be aware that responding to emotions may enhance rather than diminish the patient–provider relationship

  • Remain cognizant of situations in one’s own life that may impact comfort level (e.g. death of a loved one, one’s personal health challenges) and seek counselling as appropriate

  • Seek peer/professional consultation to develop strategies to manage emotional distress

At ACHD programme/institutional level
 Ambiguity regarding who is responsible for initiating and maintaining the ACP dialogue
  • Acknowledge that adults with CHD prefer to discuss ACP with clinicians whom they trust

  • Develop a standardized process for identifying the team member who is responsible for overseeing ACP

 Lack of time
  • Advocate for a clinical scheduling practice that allows sufficient time to discuss ACP within a routine outpatient visit

  • Schedule ACP-specific clinical visits

  • Recognize that time might be more flexible within the inpatient setting

BarrierStrategies for healthcare providers
At patient level
 No/minimal knowledge about ACPProvide education about the rationale for ACP
 Reluctance to begin this discussion
  • Introduce and normalize this topic in broader terms during a routine clinic visit and offer the opportunity to discuss in more detail at a follow-up visit

  • Encourage patients to have loved ones present for these conversations

  • Introduce ACP during situations when it seems to occur more naturally (e.g. death of a close family member or an ACHD peer, family planning, prior to cardiac intervention)

 Avoidance of discussion of health deterioration (which might be amplified during acute cardiac events)Initiate ACP during stable (rather than acute) phase of the disease to allow for a less-pressured patient experience
 Desire to protect family and loved onesEducate about the advantages of ACP communication and advance directives for family members should they be faced making treatment or care decisions for the patient in the future
At healthcare provider level
 Fear of causing patients to experience unnecessary emotional distress
  • Acknowledge that emotional reactions to disappointing information are understandable

  • Acknowledge and label emotional reactions as they occur

  • Strive for a balance between preparation for undesired outcomes and maintaining hope; emphasize that these are not mutually exclusive

  • Emphasize that ACP is intended to be an empowering process for patients and their loved ones

 Uncertainty about prognosis
  • Acknowledge challenges associated with an unpredictable disease trajectory

  • Use standardized prognostic indexes (e.g. NYHA class) or results from functional testing (e.g. cardiopulmonary exercise testing) to guide predictions

  • Offer broader time ranges for life expectancy (i.e. decades vs. years vs. months vs. weeks)

 Lack of confidence and skills in ACP
  • Practice discussions with colleagues to develop comfort with this language

  • Consider a standardized approach (e.g. ask-tell-ask) to initiate discussions

  • Use a checklist to guide discussions (see Supplementary material online)

  • Seek continuing education opportunities

  • Liaise with a palliative care team to enhance skills

 Low familiarity with specific patient factors that warrant unique attention (e.g. culture, religion, background)
  • Communicate in a respectful and sensitive manner

  • Inquire about religious, cultural and background factors that may impact patients’ decision-making

  • Maintain a respectful curiosity regarding patients’ beliefs and practices

  • Avoid assumptions based on patients’ culture, religion, or background

 Personal discomfort with ACP discussions and end-of-life care
  • Acknowledge that emotional reactions are understandable

  • Be aware that responding to emotions may enhance rather than diminish the patient–provider relationship

  • Remain cognizant of situations in one’s own life that may impact comfort level (e.g. death of a loved one, one’s personal health challenges) and seek counselling as appropriate

  • Seek peer/professional consultation to develop strategies to manage emotional distress

At ACHD programme/institutional level
 Ambiguity regarding who is responsible for initiating and maintaining the ACP dialogue
  • Acknowledge that adults with CHD prefer to discuss ACP with clinicians whom they trust

  • Develop a standardized process for identifying the team member who is responsible for overseeing ACP

 Lack of time
  • Advocate for a clinical scheduling practice that allows sufficient time to discuss ACP within a routine outpatient visit

  • Schedule ACP-specific clinical visits

  • Recognize that time might be more flexible within the inpatient setting

ACHD, adult CHD; ACP, advance care planning; CHD, congenital heart disease; NYHA, New York Heart Association.

Table 1

Barriers to advance care planning communication and proposed clinical strategies

BarrierStrategies for healthcare providers
At patient level
 No/minimal knowledge about ACPProvide education about the rationale for ACP
 Reluctance to begin this discussion
  • Introduce and normalize this topic in broader terms during a routine clinic visit and offer the opportunity to discuss in more detail at a follow-up visit

  • Encourage patients to have loved ones present for these conversations

  • Introduce ACP during situations when it seems to occur more naturally (e.g. death of a close family member or an ACHD peer, family planning, prior to cardiac intervention)

 Avoidance of discussion of health deterioration (which might be amplified during acute cardiac events)Initiate ACP during stable (rather than acute) phase of the disease to allow for a less-pressured patient experience
 Desire to protect family and loved onesEducate about the advantages of ACP communication and advance directives for family members should they be faced making treatment or care decisions for the patient in the future
At healthcare provider level
 Fear of causing patients to experience unnecessary emotional distress
  • Acknowledge that emotional reactions to disappointing information are understandable

  • Acknowledge and label emotional reactions as they occur

  • Strive for a balance between preparation for undesired outcomes and maintaining hope; emphasize that these are not mutually exclusive

  • Emphasize that ACP is intended to be an empowering process for patients and their loved ones

 Uncertainty about prognosis
  • Acknowledge challenges associated with an unpredictable disease trajectory

  • Use standardized prognostic indexes (e.g. NYHA class) or results from functional testing (e.g. cardiopulmonary exercise testing) to guide predictions

  • Offer broader time ranges for life expectancy (i.e. decades vs. years vs. months vs. weeks)

 Lack of confidence and skills in ACP
  • Practice discussions with colleagues to develop comfort with this language

  • Consider a standardized approach (e.g. ask-tell-ask) to initiate discussions

  • Use a checklist to guide discussions (see Supplementary material online)

  • Seek continuing education opportunities

  • Liaise with a palliative care team to enhance skills

 Low familiarity with specific patient factors that warrant unique attention (e.g. culture, religion, background)
  • Communicate in a respectful and sensitive manner

  • Inquire about religious, cultural and background factors that may impact patients’ decision-making

  • Maintain a respectful curiosity regarding patients’ beliefs and practices

  • Avoid assumptions based on patients’ culture, religion, or background

 Personal discomfort with ACP discussions and end-of-life care
  • Acknowledge that emotional reactions are understandable

  • Be aware that responding to emotions may enhance rather than diminish the patient–provider relationship

  • Remain cognizant of situations in one’s own life that may impact comfort level (e.g. death of a loved one, one’s personal health challenges) and seek counselling as appropriate

  • Seek peer/professional consultation to develop strategies to manage emotional distress

At ACHD programme/institutional level
 Ambiguity regarding who is responsible for initiating and maintaining the ACP dialogue
  • Acknowledge that adults with CHD prefer to discuss ACP with clinicians whom they trust

  • Develop a standardized process for identifying the team member who is responsible for overseeing ACP

 Lack of time
  • Advocate for a clinical scheduling practice that allows sufficient time to discuss ACP within a routine outpatient visit

  • Schedule ACP-specific clinical visits

  • Recognize that time might be more flexible within the inpatient setting

BarrierStrategies for healthcare providers
At patient level
 No/minimal knowledge about ACPProvide education about the rationale for ACP
 Reluctance to begin this discussion
  • Introduce and normalize this topic in broader terms during a routine clinic visit and offer the opportunity to discuss in more detail at a follow-up visit

  • Encourage patients to have loved ones present for these conversations

  • Introduce ACP during situations when it seems to occur more naturally (e.g. death of a close family member or an ACHD peer, family planning, prior to cardiac intervention)

 Avoidance of discussion of health deterioration (which might be amplified during acute cardiac events)Initiate ACP during stable (rather than acute) phase of the disease to allow for a less-pressured patient experience
 Desire to protect family and loved onesEducate about the advantages of ACP communication and advance directives for family members should they be faced making treatment or care decisions for the patient in the future
At healthcare provider level
 Fear of causing patients to experience unnecessary emotional distress
  • Acknowledge that emotional reactions to disappointing information are understandable

  • Acknowledge and label emotional reactions as they occur

  • Strive for a balance between preparation for undesired outcomes and maintaining hope; emphasize that these are not mutually exclusive

  • Emphasize that ACP is intended to be an empowering process for patients and their loved ones

 Uncertainty about prognosis
  • Acknowledge challenges associated with an unpredictable disease trajectory

  • Use standardized prognostic indexes (e.g. NYHA class) or results from functional testing (e.g. cardiopulmonary exercise testing) to guide predictions

  • Offer broader time ranges for life expectancy (i.e. decades vs. years vs. months vs. weeks)

 Lack of confidence and skills in ACP
  • Practice discussions with colleagues to develop comfort with this language

  • Consider a standardized approach (e.g. ask-tell-ask) to initiate discussions

  • Use a checklist to guide discussions (see Supplementary material online)

  • Seek continuing education opportunities

  • Liaise with a palliative care team to enhance skills

 Low familiarity with specific patient factors that warrant unique attention (e.g. culture, religion, background)
  • Communicate in a respectful and sensitive manner

  • Inquire about religious, cultural and background factors that may impact patients’ decision-making

  • Maintain a respectful curiosity regarding patients’ beliefs and practices

  • Avoid assumptions based on patients’ culture, religion, or background

 Personal discomfort with ACP discussions and end-of-life care
  • Acknowledge that emotional reactions are understandable

  • Be aware that responding to emotions may enhance rather than diminish the patient–provider relationship

  • Remain cognizant of situations in one’s own life that may impact comfort level (e.g. death of a loved one, one’s personal health challenges) and seek counselling as appropriate

  • Seek peer/professional consultation to develop strategies to manage emotional distress

At ACHD programme/institutional level
 Ambiguity regarding who is responsible for initiating and maintaining the ACP dialogue
  • Acknowledge that adults with CHD prefer to discuss ACP with clinicians whom they trust

  • Develop a standardized process for identifying the team member who is responsible for overseeing ACP

 Lack of time
  • Advocate for a clinical scheduling practice that allows sufficient time to discuss ACP within a routine outpatient visit

  • Schedule ACP-specific clinical visits

  • Recognize that time might be more flexible within the inpatient setting

ACHD, adult CHD; ACP, advance care planning; CHD, congenital heart disease; NYHA, New York Heart Association.

Staged implementation of advance care planning

Advance care planning is a gradual process that is initiated by exploring a person’s understanding of the aims and potential benefits of ACP and discussing their personal readiness for decision-making. Information about a person’s health-related experiences, values, psychosocial resources, concerns, and expectations should be sought. Given the diversity in cultural and religious approaches to death and dying both between and within countries, a culturally sensitive approach is essential.42 Assumptions should be avoided and provider is encouraged to approach discussions with a respectful curiosity. It should be noted, however, that core principles of ACP, such as the expression of respect and compassion, and alleviation of unnecessary distress, are largely similar across ethnic and cultural groups.43  ,  44 Open and sensitive communication concordant with personal needs and values should include an explanation of how the CHD diagnosis impacts longer-term health expectations and anticipated disease progression, prognosis, and the advantages and disadvantages of potential treatment options.29 This allows providers to individualize ACP to the expected timing of health deterioration. As such, we suggest a staged implementation of the ACP process as outlined in Table 2. Within every stage of ACP, patients should be given the opportunity to involve family members or loved ones and also to reflect and clarify previously documented wishes; as such, ACP is an iterative process (Take home figure).

Table 2

Staged implementation of advance care planning  a

WhoActionSteps
Stage 1Anticipated life expectancy: decade(s) Adult with CHD with any of the following
  • expressing interest in future health discussion (e.g. during transition to adulthood)

  • having unrealistic health expectations, particularly when confronted with important life planning decisions (e.g. family planning)

  • reduced life expectancy, such as - adults with Fontan procedure - adults with cyanotic heart disease - adults with a systemic right ventricle approaching 40 years of age

  • Invite discussions about future health expectations and preferences

  • Explain the rationale and advantages of ACP

  • Discuss future health expectations, while acknowledging challenges with longer-term prognostication

  • Inquire about personal preferences, goals and personal values

  • Offer to include relatives or loved ones in the conversation

  • Schedule dedicated outpatient visit(s) for the purpose, as appropriate

  • Provide written documentation in medical records of elements discussed

  • Share information with general practitioner and other healthcare professionals

Stage 2Anticipated life expectancy: years Adult with CHD with any of the following
  • expressing interest in ACP discussion

  • before CRT or ICD implantation

  • at the time of diagnosis with advanced heart failure, particularly before heart transplant assessment22

  • requiring cardiac surgery, complex catheter-based therapeutic interventions

  • Revisit the elements discussed at stage 1 and

  • Offer more comprehensive ACP discussion

  • Prepare or review advance directives including the nomination of a healthcare representative

  • Inform and discuss about POLST

  • Schedule dedicated outpatient visit or facilitate ACP discussion during an inpatient stay

  • Provide an update of written documentation of ACP, if applicable

  • Document advance directives (including healthcare representative) and/or POLST and share this information with all stakeholders

Stage 3Anticipated life expectancy: weeks to months Adult with CHD with any of the following
  • their provider would not be surprised if the patient died within the next year

  • refractory end-stage heart failure21,22 (e.g. a failing Fontan circulation; repeated re-admission for decompensated heart failure requiring inotropic support and/or ICU stay; if temporary or long-term mechanical circulatory support is considered or may arise in due management course)

  • Revisit the elements discussed at stage 2 and

  • Discuss end-of-life preferences, including the location of death

  • Organize support for family members

  • Involve palliative care team as appropriate

  • As appropriate, discuss deactivation of implanted cardiac device functions

  • Update written ACP documents as applicable

  • Consider organization of home care

  • Consider involvement of social work

  • Consider involvement of palliative care

  • Consider involvement of psychology and/or religious support providers

Stage 4Anticipated life expectancy: days The dying adult with CHD
  • Provide end-of-life care reflecting personal preferences and documented directives

  • Co-ordinate bereavement care for loved ones, as appropriate

  • Consider involvement of social work

  • Consider involvement of palliative care

  • Consider involvement of psychology and/or religious support providers

  • Provide support to care team as necessary

WhoActionSteps
Stage 1Anticipated life expectancy: decade(s) Adult with CHD with any of the following
  • expressing interest in future health discussion (e.g. during transition to adulthood)

  • having unrealistic health expectations, particularly when confronted with important life planning decisions (e.g. family planning)

  • reduced life expectancy, such as - adults with Fontan procedure - adults with cyanotic heart disease - adults with a systemic right ventricle approaching 40 years of age

  • Invite discussions about future health expectations and preferences

  • Explain the rationale and advantages of ACP

  • Discuss future health expectations, while acknowledging challenges with longer-term prognostication

  • Inquire about personal preferences, goals and personal values

  • Offer to include relatives or loved ones in the conversation

  • Schedule dedicated outpatient visit(s) for the purpose, as appropriate

  • Provide written documentation in medical records of elements discussed

  • Share information with general practitioner and other healthcare professionals

Stage 2Anticipated life expectancy: years Adult with CHD with any of the following
  • expressing interest in ACP discussion

  • before CRT or ICD implantation

  • at the time of diagnosis with advanced heart failure, particularly before heart transplant assessment22

  • requiring cardiac surgery, complex catheter-based therapeutic interventions

  • Revisit the elements discussed at stage 1 and

  • Offer more comprehensive ACP discussion

  • Prepare or review advance directives including the nomination of a healthcare representative

  • Inform and discuss about POLST

  • Schedule dedicated outpatient visit or facilitate ACP discussion during an inpatient stay

  • Provide an update of written documentation of ACP, if applicable

  • Document advance directives (including healthcare representative) and/or POLST and share this information with all stakeholders

Stage 3Anticipated life expectancy: weeks to months Adult with CHD with any of the following
  • their provider would not be surprised if the patient died within the next year

  • refractory end-stage heart failure21,22 (e.g. a failing Fontan circulation; repeated re-admission for decompensated heart failure requiring inotropic support and/or ICU stay; if temporary or long-term mechanical circulatory support is considered or may arise in due management course)

  • Revisit the elements discussed at stage 2 and

  • Discuss end-of-life preferences, including the location of death

  • Organize support for family members

  • Involve palliative care team as appropriate

  • As appropriate, discuss deactivation of implanted cardiac device functions

  • Update written ACP documents as applicable

  • Consider organization of home care

  • Consider involvement of social work

  • Consider involvement of palliative care

  • Consider involvement of psychology and/or religious support providers

Stage 4Anticipated life expectancy: days The dying adult with CHD
  • Provide end-of-life care reflecting personal preferences and documented directives

  • Co-ordinate bereavement care for loved ones, as appropriate

  • Consider involvement of social work

  • Consider involvement of palliative care

  • Consider involvement of psychology and/or religious support providers

  • Provide support to care team as necessary

ACP, advance care planning; CHD, congenital heart disease; CRT, cardiac resynchronization therapy; ICD, implantable cardioverter defibrillator; ICU, intensive care unit; POLST, Physician Orders for Life-Sustaining Treatment.

a

Adapted table from ‘Staged implementation of advance care planning, anticipatory care planning and integrated end-of-life care planning’.30

Table 2

Staged implementation of advance care planning  a

WhoActionSteps
Stage 1Anticipated life expectancy: decade(s) Adult with CHD with any of the following
  • expressing interest in future health discussion (e.g. during transition to adulthood)

  • having unrealistic health expectations, particularly when confronted with important life planning decisions (e.g. family planning)

  • reduced life expectancy, such as - adults with Fontan procedure - adults with cyanotic heart disease - adults with a systemic right ventricle approaching 40 years of age

  • Invite discussions about future health expectations and preferences

  • Explain the rationale and advantages of ACP

  • Discuss future health expectations, while acknowledging challenges with longer-term prognostication

  • Inquire about personal preferences, goals and personal values

  • Offer to include relatives or loved ones in the conversation

  • Schedule dedicated outpatient visit(s) for the purpose, as appropriate

  • Provide written documentation in medical records of elements discussed

  • Share information with general practitioner and other healthcare professionals

Stage 2Anticipated life expectancy: years Adult with CHD with any of the following
  • expressing interest in ACP discussion

  • before CRT or ICD implantation

  • at the time of diagnosis with advanced heart failure, particularly before heart transplant assessment22

  • requiring cardiac surgery, complex catheter-based therapeutic interventions

  • Revisit the elements discussed at stage 1 and

  • Offer more comprehensive ACP discussion

  • Prepare or review advance directives including the nomination of a healthcare representative

  • Inform and discuss about POLST

  • Schedule dedicated outpatient visit or facilitate ACP discussion during an inpatient stay

  • Provide an update of written documentation of ACP, if applicable

  • Document advance directives (including healthcare representative) and/or POLST and share this information with all stakeholders

Stage 3Anticipated life expectancy: weeks to months Adult with CHD with any of the following
  • their provider would not be surprised if the patient died within the next year

  • refractory end-stage heart failure21,22 (e.g. a failing Fontan circulation; repeated re-admission for decompensated heart failure requiring inotropic support and/or ICU stay; if temporary or long-term mechanical circulatory support is considered or may arise in due management course)

  • Revisit the elements discussed at stage 2 and

  • Discuss end-of-life preferences, including the location of death

  • Organize support for family members

  • Involve palliative care team as appropriate

  • As appropriate, discuss deactivation of implanted cardiac device functions

  • Update written ACP documents as applicable

  • Consider organization of home care

  • Consider involvement of social work

  • Consider involvement of palliative care

  • Consider involvement of psychology and/or religious support providers

Stage 4Anticipated life expectancy: days The dying adult with CHD
  • Provide end-of-life care reflecting personal preferences and documented directives

  • Co-ordinate bereavement care for loved ones, as appropriate

  • Consider involvement of social work

  • Consider involvement of palliative care

  • Consider involvement of psychology and/or religious support providers

  • Provide support to care team as necessary

WhoActionSteps
Stage 1Anticipated life expectancy: decade(s) Adult with CHD with any of the following
  • expressing interest in future health discussion (e.g. during transition to adulthood)

  • having unrealistic health expectations, particularly when confronted with important life planning decisions (e.g. family planning)

  • reduced life expectancy, such as - adults with Fontan procedure - adults with cyanotic heart disease - adults with a systemic right ventricle approaching 40 years of age

  • Invite discussions about future health expectations and preferences

  • Explain the rationale and advantages of ACP

  • Discuss future health expectations, while acknowledging challenges with longer-term prognostication

  • Inquire about personal preferences, goals and personal values

  • Offer to include relatives or loved ones in the conversation

  • Schedule dedicated outpatient visit(s) for the purpose, as appropriate

  • Provide written documentation in medical records of elements discussed

  • Share information with general practitioner and other healthcare professionals

Stage 2Anticipated life expectancy: years Adult with CHD with any of the following
  • expressing interest in ACP discussion

  • before CRT or ICD implantation

  • at the time of diagnosis with advanced heart failure, particularly before heart transplant assessment22

  • requiring cardiac surgery, complex catheter-based therapeutic interventions

  • Revisit the elements discussed at stage 1 and

  • Offer more comprehensive ACP discussion

  • Prepare or review advance directives including the nomination of a healthcare representative

  • Inform and discuss about POLST

  • Schedule dedicated outpatient visit or facilitate ACP discussion during an inpatient stay

  • Provide an update of written documentation of ACP, if applicable

  • Document advance directives (including healthcare representative) and/or POLST and share this information with all stakeholders

Stage 3Anticipated life expectancy: weeks to months Adult with CHD with any of the following
  • their provider would not be surprised if the patient died within the next year

  • refractory end-stage heart failure21,22 (e.g. a failing Fontan circulation; repeated re-admission for decompensated heart failure requiring inotropic support and/or ICU stay; if temporary or long-term mechanical circulatory support is considered or may arise in due management course)

  • Revisit the elements discussed at stage 2 and

  • Discuss end-of-life preferences, including the location of death

  • Organize support for family members

  • Involve palliative care team as appropriate

  • As appropriate, discuss deactivation of implanted cardiac device functions

  • Update written ACP documents as applicable

  • Consider organization of home care

  • Consider involvement of social work

  • Consider involvement of palliative care

  • Consider involvement of psychology and/or religious support providers

Stage 4Anticipated life expectancy: days The dying adult with CHD
  • Provide end-of-life care reflecting personal preferences and documented directives

  • Co-ordinate bereavement care for loved ones, as appropriate

  • Consider involvement of social work

  • Consider involvement of palliative care

  • Consider involvement of psychology and/or religious support providers

  • Provide support to care team as necessary

ACP, advance care planning; CHD, congenital heart disease; CRT, cardiac resynchronization therapy; ICD, implantable cardioverter defibrillator; ICU, intensive care unit; POLST, Physician Orders for Life-Sustaining Treatment.

a

Adapted table from ‘Staged implementation of advance care planning, anticipatory care planning and integrated end-of-life care planning’.30

When speaking with an adult with CHD with minimal anticipated major health problems in the upcoming years, it may be sufficient for the ACP discussion to include predicted long-term health outcomes and to explore a person’s values, goals, and concerns for the future. During these discussions, the provider might discover that patient’s expectations are in fact more pessimistic than would be predicted from long-term follow-up studies. The results of one study indicated that adults with CHD of low complexity were more likely to want information about the average life expectancy compared to those with CHD of moderate or great complexity.26 In some of these cases, discussions of long-term health expectations might be interpreted with reassurance and relief.25

For adults with CHD facing health deterioration, discussions about preferences for interventions and life-sustaining treatments become more pertinent and would ideally result in advance directives, including the naming of a healthcare representative, and Physician Orders for Life-Sustaining Treatment (healthcare representative; see Box 2—glossary of terms) that should be made accessible to all healthcare providers involved in the care process.35  Figure 2 illustrates how the content of ACP discussions can transition from general information about future health expectations to more specific topics in accordance with disease progression.

In accordance with advanced disease progression, discussion may transition from general health expectations to more specific topics. It is helpful for patients, loved ones, and providers to prepare for in ‘in-the-moment decision-making’ in acute health situations in ways that reflect patients’ known preferences and priorities. Over time, an individual’s care needs may shift from active, disease-targeted therapies (green), through periods of increasing symptoms and disability requiring more palliative care measures (purple). Active and palliative care strategies are not mutually exclusive (shades of blue). POLST, Physician Orders for Life-Sustaining Treatment.
Figure 2

In accordance with advanced disease progression, discussion may transition from general health expectations to more specific topics. It is helpful for patients, loved ones, and providers to prepare for in ‘in-the-moment decision-making’ in acute health situations in ways that reflect patients’ known preferences and priorities. Over time, an individual’s care needs may shift from active, disease-targeted therapies (green), through periods of increasing symptoms and disability requiring more palliative care measures (purple). Active and palliative care strategies are not mutually exclusive (shades of blue). POLST, Physician Orders for Life-Sustaining Treatment.

Advance care planning is a staged and iterative process rather than a one-time event. Advance care planning supports and empowers individuals to consider and communicate preferences for future health care based on their personal values and beliefs, should they be unable to express their wishes at that time. Within every stage of advance care planning, patients should be given the opportunity to involve family members or loved ones and also to reflect and clarify previously-documented wishes. Most adults with congenital heart disease prefer to have discussions about advance care planning care with their treating adult congenital heart disease physician. A trusting relationship is a facilitator for the initiation of such discussions. The notion of disease progression and specific triggers should raise awareness of the adult congenital heart disease specialist to mention and initiate advance care planning, if whished by the patient. CHD, congenital heart disease.
Take home figure

Advance care planning is a staged and iterative process rather than a one-time event. Advance care planning supports and empowers individuals to consider and communicate preferences for future health care based on their personal values and beliefs, should they be unable to express their wishes at that time. Within every stage of advance care planning, patients should be given the opportunity to involve family members or loved ones and also to reflect and clarify previously-documented wishes. Most adults with congenital heart disease prefer to have discussions about advance care planning care with their treating adult congenital heart disease physician. A trusting relationship is a facilitator for the initiation of such discussions. The notion of disease progression and specific triggers should raise awareness of the adult congenital heart disease specialist to mention and initiate advance care planning, if whished by the patient. CHD, congenital heart disease.

As a person’s condition deteriorates further such that the possibility of death increases, discussions can be extended with specific questions related to end-of-life wishes, including issues related to the modification of cardiac devices (e.g. deactivation of shocking function of an ICD), specific treatments to consider and avoid, and palliative care measures.

Interprofessional collaboration (e.g. palliative care professionals, social workers, psychologists, spiritual advisors) may be particularly helpful in situations in which (i) patients and/or loved ones are struggling with the disease trajectory, (ii) disagreements exist between the patient, family, and care teams, or (iii) challenges arise in managing physical and/or psychological symptoms. It is important to emphasize to patients and loved ones that active disease-specific care can continue in parallel with palliative care if consistent with patients’ preferences and goals.17  ,  45  ,  46 The supporting role of palliative care for the family and loved ones goes beyond the person’s death and includes bereavement counselling.47

Structural requirements for implementing advance care planning in regular adult congenital heart disease practice

Effective ACP sometimes requires an interdisciplinary team approach.48 In addition to the ACHD team (i.e. typically cardiologists and nurses), other members of the interdisciplinary team reflect needs of the person and his/her family (e.g. general practitioners, other subspecialists, social workers, spiritual care providers, psychologists, legal counsellors, palliative care specialists).49 Within the team, it is important to identify the co-ordinating lead who may thus assign specific tasks to other team members. This is often the patient’s identified primary ACHD cardiologist, who most patients consider the most appropriate person to initiate ACP discussions.23 Advanced practice nurses (e.g. nurse practitioners) are also well suited for this oversight role, given their holistic approach and often long-term relationships with patients.50

In addition to staffing considerations, a set of programmatic processes is necessary to ensure regular review and accessible storage of advance directives.13 Legal requirements, such as the binding effects of ACP documents, identification of one’s healthcare representative, and matters related to assisted dying, depend upon laws of one’s local jurisdiction.42 At a minimum, ACP documents should be declared as ‘statements of wishes to be given due respect’.51 A formal document signed by patients and witnesses is ideal. This document should be easily identifiable and accessible within the electronic and/or paper medical record and not merely summarized in a clinical progress note. The aim is to ensure access by all inpatient and outpatient health providers.29 It is also advised that patients provide family members and new healthcare providers with a copy of their advance directives to ensure at the time of admission, the patient or the persons most involved with its medical support, have a hard copy or an electronic version at hand. Advance care planning preferences and decisions may change over time. It is important for ACHD providers to revisit this topic over time, and to adjust the corresponding documents accordingly. Providers may also require about the presence of externally prepared ACP documents (e.g. completed with a lawyer). If available, the recommendation to include these in the medical record should be offered.

Provider training in ACP and end-of-life discussion is associated with increased ease and comfort to initiate ACP discussions.52 Communication during the ACP process may be challenging for all stakeholders. Practical tools such as the Six Step Protocol for Delivering Bad News or the ‘ask-tell-ask’ algorithm can help healthcare professionals to communicate bad news in an effective but compassionate way.15  ,  53 Information on national courses is available through the European Association for Palliative Care (www.eapcnet.eu). Given that ACP discussions can be emotionally burdensome, 54  ,  55 it is advised that providers receive training in coping strategies and have support systems in place.

Summary

Advance care planning has emerged as an integral part of comprehensive care for adults with CHD. It should be offered during routine clinical practice to all interested persons and particularly to those at risk for significant deterioration in the near future. We suggest that ACP be delivered as a structured process across different stages, with content dependent upon the anticipated disease progression. We acknowledge potential barriers to initiate ACP discussions and emphasize the importance of a sensitive, responsive, and adaptable communication style. Advance care planning benefits from a team approach, provider training, adequate staffing, and a systematic approach to documentation. Death is an inevitable outcome for all. Supporting patients to be well prepared for their final journey may be one of the most challenging and also rewarding experiences for ACHD providers.

Conflict of interest: none declared.

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

References

1

Marelli
 
AJ
,
Ionescu-Ittu
 
R
,
Mackie
 
AS
,
Guo
 
L
,
Dendukuri
 
N
,
Kaouache
 
M.
 
Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010
.
Circulation
 
2014
;
130
:
749
756
.

2

Khairy
 
P
,
Ionescu-Ittu
 
R
,
Mackie
 
AS
,
Abrahamowicz
 
M
,
Pilote
 
L
,
Marelli
 
AJ.
 
Changing mortality in congenital heart disease
.
J Am Coll Cardiol
 
2010
;
56
:
1149
1157
.

3

Tutarel
 
O
,
Kempny
 
A
,
Alonso-Gonzalez
 
R
,
Jabbour
 
R
,
Li
 
W
,
Uebing
 
A
,
Dimopoulos
 
K
,
Swan
 
L
,
Gatzoulis
 
MA
,
Diller
 
GP.
 
Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality
.
Eur Heart J
 
2014
;
35
:
725
732
.

4

Baumgartner
 
H.
 
Geriatric congenital heart disease: a new challenge in the care of adults with congenital heart disease?
 
Eur Heart J
 
2014
;
35
:
683
685
.

5

Bhatt
 
AB
,
Foster
 
E
,
Kuehl
 
K
,
Alpert
 
J
,
Brabeck
 
S
,
Crumb
 
S
,
Davidson
 
WR
 Jr.
,
Earing
 
MG
,
Ghoshhajra
 
BB
,
Karamlou
 
T
,
Mital
 
S
,
Ting
 
J
,
Tseng
 
ZH
; American Heart Association Council on Clinical Cardiology.
Congenital heart disease in the older adult: a scientific statement from the American Heart Association
.
Circulation
 
2015
;
131
:
1884
1931
.

6

Bracher
 
I
,
Padrutt
 
M
,
Bonassin
 
F
,
Santos Lopes
 
B
,
Gruner
 
C
,
Stampfli
 
SF
,
Oxenius
 
A
,
De Pasquale
 
G
,
Seeliger
 
T
,
Luscher
 
TF
,
Attenhofer Jost
 
C
,
Greutmann
 
M.
 
Burden and impact of congenital syndromes and comorbidities among adults with congenital heart disease
.
Int J Cardiol
 
2017
;
240
:
159
164
.

7

Erikssen
 
G
,
Liestol
 
K
,
Seem
 
E
,
Birkeland
 
S
,
Saatvedt
 
KJ
,
Hoel
 
TN
,
Dohlen
 
G
,
Skulstad
 
H
,
Svennevig
 
JL
,
Thaulow
 
E
,
Lindberg
 
HL.
 
Achievements in congenital heart defect surgery: a prospective, 40-year study of 7038 patients
.
Circulation
 
2015
;
131
:
337
346; discussion 346
.

8

Moons
 
P
,
Bovijn
 
L
,
Budts
 
W
,
Belmans
 
A
,
Gewillig
 
M.
 
Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium
.
Circulation
 
2010
;
122
:
2264
2272
.

9

Oliver
 
JM
,
Gallego
 
P
,
Gonzalez
 
AE
,
Garcia-Hamilton
 
D
,
Avila
 
P
,
Yotti
 
R
,
Ferreira
 
I
,
Fernandez-Aviles
 
F.
 
Risk factors for excess mortality in adults with congenital heart diseases
.
Eur Heart J
 
2017
;
38
:
1233
1241
.

10

Oliver
 
JM
,
Gallego
 
P
,
Gonzalez
 
AE
,
Garcia-Hamilton
 
D
,
Avila
 
P
,
Alonso
 
A
,
Ruiz-Cantador
 
J
,
Peinado
 
R
,
Yotti
 
R
,
Fernandez-Aviles
 
F.
 
Impact of age and sex on survival and causes of death in adults with congenital heart disease
.
Int J Cardiol
 
2017
;
245
:
119
124
.

11

Troost
 
E
,
Roggen
 
L
,
Goossens
 
E
,
Moons
 
P
,
De Meester
 
P
,
Van De Bruaene
 
A
,
Budts
 
W.
 
Advanced care planning in adult congenital heart disease: transitioning from repair to palliation and end-of-life care
.
International Journal of Cardiology
 
2019
;
279
:
57
61
.

12

Ludmir
 
J
,
Steiner
 
JM
,
Wong
 
H-N
,
Kloosterboer
 
A
,
Leong
 
J
,
Aslakson
 
RA
,
Aslakson
 
R
,
Ast
 
K
,
Carroll
 
T
,
Dzeng
 
E
,
Harrison
 
KL
,
Kaye
 
EC
,
LeBlanc
 
TW
,
Lo
 
SS
,
McKenna
 
K
,
Nageswaran
 
S
,
Powers
 
J
,
Rotella
 
J
,
Ullrich
 
C
,
Vickey
 
T.
 
Palliative care opportunities among adults with congenital heart disease—a systematic review
.
J Pain Symptom Manage
 
2019
;
58
:
891
898
.

13

Sudore
 
RL
,
Fried
 
TR.
 
Redefining the “planning” in advance care planning: preparing for end-of-life decision making
.
Ann Intern Med
 
2010
;
153
:
256
261
.

14

Brighton
 
LJ
,
Bristowe
 
K.
 
Communication in palliative care: talking about the end of life, before the end of life
.
Postgrad Med J
 
2016
;
92
:
466
470
.

15

Kovacs
 
AH
,
Landzberg
 
MJ
,
Goodlin
 
SJ.
 
Advance care planning and end-of-life management of adult patients with congenital heart disease
.
World J Pediatr Congenit Heart Surg
 
2013
;
4
:
62
69
.

16

Bernacki
 
RE
,
Block
 
SD
; American College of Physicians High Value Care Task Force.
Communication about serious illness care goals: a review and synthesis of best practices
.
JAMA Intern Med
 
2014
;
174
:
1994
2003
.

17

Sobanski
 
P Z
 
Alt-Epping
 
B
 
Currow
 
D C
 
Goodlin
 
S J
 
Grodzicki
 
T
 
Hogg
 
K
 
Janssen
 
D J A
 
Johnson
 
M J
 
Krajnik
 
M
 
Leget
 
C
 
Martínez-Sellés
 
M
 
Moroni
 
M
 
Mueller
 
P S
 
Ryder
 
M
 
Simon
 
S T
 
Stowe
 
E
 
Larkin
 
P J.
 
Palliative care for people living with heart failure: European Association for Palliative Care Task Force expert position statement
.
Cardiovasc Res
 
2020
;
116
:
12
27
.

18

Steiner
 
JM
,
Cooper
 
S
,
Kirkpatrick
 
JN.
 
Palliative care in end-stage valvular heart disease
.
Heart
 
2017
;
103
:
1233
1237
.

19

Braun
 
LT
,
Grady
 
KL
,
Kutner
 
JS
,
Adler
 
E
,
Berlinger
 
N
,
Boss
 
R
,
Butler
 
J
,
Enguidanos
 
S
,
Friebert
 
S
,
Gardner
 
TJ
,
Higgins
 
P
,
Holloway
 
R
,
Konig
 
M
,
Meier
 
D
,
Morrissey
 
MB
,
Quest
 
TE
,
Wiegand
 
DL
,
Coombs-Lee
 
B
,
Fitchett
 
G
,
Gupta
 
C
,
Roach
 
WH.
 Jr.
; American Heart Association Advocacy Coordinating Committee.
Palliative care and cardiovascular disease and stroke: a policy statement from the American Heart Association/American Stroke Association
.
Circulation
 
2016
;
134
:
e198
.

20

Ponikowski
 
P
,
Voors
 
AA
,
Anker
 
SD
,
Bueno
 
H
,
Cleland
 
JG
,
Coats
 
AJ
,
Falk
 
V
,
Gonzalez-Juanatey
 
JR
,
Harjola
 
VP
,
Jankowska
 
EA
,
Jessup
 
M
,
Linde
 
C
,
Nihoyannopoulos
 
P
,
Parissis
 
JT
,
Pieske
 
B
,
Riley
 
JP
,
Rosano
 
GM
,
Ruilope
 
LM
,
Ruschitzka
 
F
,
Rutten
 
FH
,
van der Meer
 
P
; ESC Scientific Document Group.
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
.
Eur Heart J
 
2016
;
37
:
2129
2200
.

21

Jaarsma
 
T
,
Beattie
 
JM
,
Ryder
 
M
,
Rutten
 
FH
,
McDonagh
 
T
,
Mohacsi
 
P
,
Murray
 
SA
,
Grodzicki
 
T
,
Bergh
 
I
,
Metra
 
M
,
Ekman
 
I
,
Angermann
 
C
,
Leventhal
 
M
,
Pitsis
 
A
,
Anker
 
SD
,
Gavazzi
 
A
,
Ponikowski
 
P
,
Dickstein
 
K
,
Delacretaz
 
E
,
Blue
 
L
,
Strasser
 
F
,
McMurray
 
J
; Advanced Heart Failure Study Group of the HFA of the ESC.
Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology
.
Eur J Heart Fail
 
2009
;
11
:
433
443
.

22

Fang
 
JC
,
Ewald
 
GA
,
Allen
 
LA
,
Butler
 
J
,
Westlake Canary
 
CA
,
Colvin-Adams
 
M
,
Dickinson
 
MG
,
Levy
 
P
,
Stough
 
WG
,
Sweitzer
 
NK
,
Teerlink
 
JR
,
Whellan
 
DJ
,
Albert
 
NM
,
Krishnamani
 
R
,
Rich
 
MW
,
Walsh
 
MN
,
Bonnell
 
MR
,
Carson
 
PE
,
Chan
 
MC
,
Dries
 
DL
,
Hernandez
 
AF
,
Hershberger
 
RE
,
Katz
 
SD
,
Moore
 
S
,
Rodgers
 
JE
,
Rogers
 
JG
,
Vest
 
AR
,
Givertz
 
MM.
 
Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee
.
J Card Fail
 
2015
;
21
:
519
534
.

23

Tobler
 
D
,
Greutmann
 
M
,
Colman
 
JM
,
Greutmann-Yantiri
 
M
,
Librach
 
LS
,
Kovacs
 
AH.
 
End-of-life in adults with congenital heart disease: a call for early communication
.
Int J Cardiol
 
2012
;
155
:
383
387
.

24

Tobler
 
D
,
Greutmann
 
M
,
Colman
 
JM
,
Greutmann-Yantiri
 
M
,
Librach
 
SL
,
Kovacs
 
AH.
 
Knowledge of and preference for advance care planning by adults with congenital heart disease
.
Am J Cardiol
 
2012
;
109
:
1797
1800
.

25

Greutmann
 
M
,
Tobler
 
D
,
Colman
 
JM
,
Greutmann-Yantiri
 
M
,
Librach
 
SL
,
Kovacs
 
AH.
 
Facilitators of and barriers to advance care planning in adult congenital heart disease
.
Congenit Heart Dis
 
2013
;
8
:
281
288
.

26

Deng
 
LX
,
Gleason
 
LP
,
Khan
 
AM
,
Drajpuch
 
D
,
Fuller
 
S
,
Goldberg
 
LA
,
Mascio
 
CE
,
Partington
 
SL
,
Tobin
 
L
,
Kim
 
YY
,
Kovacs
 
AH.
 
Advance care planning in adults with congenital heart disease: a patient priority
.
Int J Cardiol
 
2017
;
231
:
105
109
.

27

Steiner
 
JM
,
Stout
 
K
,
Soine
 
L
,
Kirkpatrick
 
JN
,
Curtis
 
JR.
 
Perspectives on advance care planning and palliative care among adults with congenital heart disease
.
Congenit Heart Dis
 
2019
;
14
:
403
409
.

28

Romo
 
RD
,
Lynn
 
J.
 
The utility and value of the “surprise question” for patients with serious illness
.
Canadian Medical Association Journal
 
2017
;
189
:
E1072
E1073
.

29

Rietjens
 
JAC
,
Sudore
 
RL
,
Connolly
 
M
,
van Delden
 
JJ
,
Drickamer
 
MA
,
Droger
 
M
,
van der Heide
 
A
,
Heyland
 
DK
,
Houttekier
 
D
,
Janssen
 
DJA
,
Orsi
 
L
,
Payne
 
S
,
Seymour
 
J
,
Jox
 
RJ
,
Korfage
 
IJ
; European Association for Palliative Care (EAPC).
Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care
.
Lancet Oncol
 
2017
;
18
:
e543
e551
.

30

Denvir
 
MA
,
Murray
 
SA
,
Boyd
 
KJ.
 
Future care planning: a first step to palliative care for all patients with advanced heart disease
.
Heart
 
2015
;
101
:
1002
1007
.

31

Stevenson
 
LW
,
O’Donnell
 
A.
 
Advanced care planning: care to plan in advance
.
JACC Heart Fail
 
2015
;
3
:
122
126
.

32

Rozzini
 
R
,
Sabatini
 
T
,
Trabucchi
 
M.
 
Prediction of 6-month mortality among older hospitalized adults
.
JAMA
 
2001
;
286
:
1315
1316
.

33

Walter
 
LC
,
Brand
 
RJ
,
Counsell
 
SR
,
Palmer
 
RM
,
Landefeld
 
CS
,
Fortinsky
 
RH
,
Covinsky
 
KE.
 
Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization
.
JAMA
 
2001
;
285
:
2987
2994
.

34

Diller
 
GP
,
Kempny
 
A
,
Alonso-Gonzalez
 
R
,
Swan
 
L
,
Uebing
 
A
,
Li
 
W
,
Babu-Narayan
 
S
,
Wort
 
SJ
,
Dimopoulos
 
K
,
Gatzoulis
 
MA.
 
Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre
.
Circulation
 
2015
;
132
:
2118
2125
.

35

Dunlay
 
S M
 
Strand
 
J J.
 
How to discuss goals of care with patients
.
Trends in Cardiovascular Medicine
 
2016
;
26
:
36
43
.

36

Clayer
 
MT.
 
Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers
.
Med J Aust
 
2007
;
187
:
478
478
.

37

Regitz-Zagrosek
 
V
,
Roos-Hesselink
 
JW
,
Bauersachs
 
J
,
Blomström-Lundqvist
 
C
,
Cífková
 
R
,
De Bonis
 
M
,
Iung
 
B
,
Johnson
 
MR
,
Kintscher
 
U
,
Kranke
 
P
,
Lang
 
IM
,
Morais
 
J
,
Pieper
 
PG
,
Presbitero
 
P
,
Price
 
S
,
Rosano
 
GMC
,
Seeland
 
U
,
Simoncini
 
T
,
Swan
 
L
,
Warnes
 
CA
,
Deaton
 
C
,
Simpson
 
IA
,
Aboyans
 
V
,
Agewall
 
S
,
Barbato
 
E
,
Calda
 
P
,
Coca
 
A
,
Coman
 
IM
,
De Backer
 
J
,
Delgado
 
V
,
Di Salvo
 
G
,
Fitzsimmons
 
S
,
Fitzsimons
 
D
,
Garbi
 
M
,
Gevaert
 
S
,
Hindricks
 
G
,
Jondeau
 
G
,
Kluin
 
J
,
Lionis
 
C
,
McDonagh
 
TA
,
Meier
 
P
,
Moons
 
P
,
Pantazis
 
A
,
Piepoli
 
MF
,
Rocca
 
B
,
Roffi
 
M
,
Rosenkranz
 
S
,
Sarkozy
 
A
,
Shlyakhto
 
E
,
Silversides
 
CK
,
Sliwa
 
K
,
Sousa-Uva
 
M
,
Tamargo
 
J
,
Thorne
 
S
,
Van de Velde
 
M
,
Williams
 
B
,
Zamorano
 
JL
,
Windecker
 
S
,
Aboyans
 
V
,
Agewall
 
S
,
Barbato
 
E
,
Bueno
 
H
,
Coca
 
A
,
Collet
 
J-P
,
Coman
 
IM
,
Dean
 
V
,
Delgado
 
V
,
Fitzsimons
 
D
,
Gaemperli
 
O
,
Hindricks
 
G
,
Iung
 
B
,
Jüni
 
P
,
Katus
 
HA
,
Knuuti
 
J
,
Lancellotti
 
P
,
Leclercq
 
C
,
McDonagh
 
TA
,
Piepoli
 
MF
,
Ponikowski
 
P
,
Richter
 
DJ
,
Roffi
 
M
,
Shlyakhto
 
E
,
Simpson
 
IA
,
Sousa-Uva
 
M
,
Zamorano
 
JL
,
Hammoudi
 
N
,
Piruzyan
 
A
,
Mascherbauer
 
J
,
Samadov
 
F
,
Prystrom
 
A
,
Pasquet
 
A
,
Caluk
 
J
,
Gotcheva
 
N
,
Skoric
 
B
,
Heracleous
 
H
,
Vejlstrup
 
N
,
Maser
 
M
,
Kaaja
 
RJ
,
Srbinovska-Kostovska
 
E
,
Mounier-Vehier
 
C
,
Vakhtangadze
 
T
,
Rybak
 
K
,
Giannakoulas
 
G
,
Kiss
 
RG
,
Thrainsdottir
 
IS
,
Erwin
 
RJ
,
Porter
 
A
,
Geraci
 
G
,
Ibrahimi
 
P
,
Lunegova
 
O
,
Mintale
 
I
,
Kadri
 
Z
,
Benlamin
 
H
,
Barysiene
 
J
,
Banu
 
CA
,
Caruana
 
M
,
Gratii
 
C
,
Haddour
 
L
,
Bouma
 
BJ
,
Estensen
 
M-E
,
Hoffman
 
P
,
Petris
 
AO
,
Moiseeva
 
O
,
Bertelli
 
L
,
Tesic
 
BV
,
Dubrava
 
J
,
Koželj
 
M
,
Prieto-Arévalo
 
R
,
Furenäs
 
E
,
Schwerzmann
 
M
,
Mourali
 
MS
,
Ozer
 
N
,
Mitchenko
 
O
,
Nelson-Piercy
 
C
; Group ESCSD.
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
.
Eur Heart J
 
2018
;
39
:
3165
3241
.

38

Cauldwell
 
M
,
Gatzoulis
 
M
,
Steer
 
P.
 
Congenital heart disease and pregnancy: a contemporary approach to counselling, pre-pregnancy investigations and the impact of pregnancy on heart function
.
Obstet Med
 
2017
;
10
:
53
57
.

39

Wiener
 
L
,
Zadeh
 
S
,
Battles
 
H
,
Baird
 
K
,
Ballard
 
E
,
Osherow
 
J
,
Pao
 
M.
 
Allowing adolescents and young adults to plan their end-of-life care
.
Pediatrics
 
2012
;
130
:
897
905
.

40

Committee on Bioethics, American Academy of Pediatrics.

Informed consent, parental permission, and assent in pediatric practice
.
Pediatrics
 
1995
;
95
:
314
317
.

41

Sable
 
C
,
Foster
 
E
,
Uzark
 
K
,
Bjornsen
 
K
,
Canobbio
 
MM
,
Connolly
 
HM
,
Graham
 
TP
,
Gurvitz
 
MZ
,
Kovacs
 
A
,
Meadows
 
AK
,
Reid
 
GJ
,
Reiss
 
JG
,
Rosenbaum
 
KN
,
Sagerman
 
PJ
,
Saidi
 
A
,
Schonberg
 
R
,
Shah
 
S
,
Tong
 
E
,
Williams
 
RG.
 
Best practices in managing transition to adulthood for adolescents with congenital heart disease: the transition process and medical and psychosocial issues: a scientific statement from the American Heart Association
.
Circulation
 
2011
;
123
:
1454
1485
.

42

Jox
 
RJ
,
Horn
 
RJ
,
Huxtable
 
R.
 
European perspectives on ethics and law in end-of-life care
.
Handb Clin Neurol
 
2013
;
118
:
155
165
.

43

Bosma
 
H
,
Apland
 
L
,
Kazanjian
 
A.
 
Cultural conceptualizations of hospice palliative care: more similarities than differences
.
Palliat Med
 
2010
;
24
:
510
522
.

44

Pereira-Salgado
 
A
,
Mader
 
P
,
O’Callaghan
 
C
,
Boyd
 
L
,
Staples
 
M.
 
Religious leaders' perceptions of advance care planning: a secondary analysis of interviews with Buddhist, Christian, Hindu, Islamic, Jewish, Sikh and Baha'i leaders
.
BMC Palliat Care
 
2017
;
16
:
79
.

45

Munoz-Mendoza
 
J.
 
Competencies in palliative care for cardiology fellows
.
J Am Coll Cardiol
 
2015
;
65
:
750
753
.

46

Kavalieratos
 
D
,
Gelfman
 
LP
,
Tycon
 
LE
,
Riegel
 
B
,
Bekelman
 
DB
,
Ikejiani
 
DZ
,
Goldstein
 
N
,
Kimmel
 
SE
,
Bakitas
 
MA
,
Arnold
 
RM.
 
Palliative care in heart failure: rationale, evidence, and future priorities
.
J Am Coll Cardiol
 
2017
;
70
:
1919
1930
.

47

Gibbs
 
JS
,
McCoy
 
AS
,
Gibbs
 
LM
,
Rogers
 
AE
,
Addington-Hall
 
JM.
 
Living with and dying from heart failure: the role of palliative care
.
Heart
 
2002
;
88 Suppl 2
:
ii36
9
.

48

National Consensus Project for Quality Palliative Care.

Clinical Practice Guidelines for Quality Palliative Care
, 4th ed.
Richmond, VA
: National Coalition for Hospice and Palliative Care;
2018
.

49

The Joint Commission. Advanced Certification for Palliative Care. Review Process Guide Orgnaization Version. Oak Brook, IL: The Joint Commission;

2015
2016
.

50

Dixon
 
J
,
Knapp
 
M.
 
Whose job? The staffing of advance care planning support in twelve international healthcare organizations: a qualitative interview study
.
BMC Palliat Care
 
2018
;
17
:
78
.

51

Ward
 
AD
; ECoLC-o (CDCJ). Enabling Citizens to Plan for Incapacity. Strasbourg, France: Council of Europe;
2018
.

52

Moir
 
C
,
Roberts
 
R
,
Martz
 
K
,
Perry
 
J
,
Tivis
 
LJ.
 
Communicating with patients and their families about palliative and end-of-life care: comfort and educational needs of nurses
.
Int J Palliat Nurs
 
2015
;
21
:
109
112
.

53

Kelemen
 
AM
,
Ruiz
 
G
,
Groninger
 
H.
 
Choosing words wisely in communication with patients with heart failure and families
.
Am J Cardiol
 
2016
;
117
:
1779
1782
.

54

Rizo-Baeza
 
M
,
Mendiola-Infante
 
SV
,
Sepehri
 
A
,
Palazón-Bru
 
A
,
Gil-Guillén
 
VF
,
Cortés-Castell
 
E.
 
Burnout syndrome in nurses working in palliative care units: an analysis of associated factors
.
J Nurs Manag
 
2018
;
26
:
19
25
.

55

Diehl
 
E
,
Rieger
 
S
,
Letzel
 
S
,
Nienhaus
 
A
,
Escobar Pinzon
 
LC.
 
Burdens and resources of nurses working in the specialist palliative care: an explorative cross-sectional study
.
Pflege
 
2019
;
32
:
209
223
.

56

Rogers
 
JG
,
Patel
 
CB
,
Mentz
 
RJ
,
Granger
 
BB
,
Steinhauser
 
KE
,
Fiuzat
 
M
,
Adams
 
PA
,
Speck
 
A
,
Johnson
 
KS
,
Krishnamoorthy
 
A
,
Yang
 
H
,
Anstrom
 
KJ
,
Dodson
 
GC
,
Taylor
 
DH
,
Kirchner
 
JL
,
Mark
 
DB
,
O’Connor
 
CM
,
Tulsky
 
JA.
 
Palliative care in heart failure: the PAL-HF Randomized, Controlled Clinical Trial
.
J Am Coll Cardiol
 
2017
;
70
:
331
341
.

57

Evangelista
 
LS
,
Lombardo
 
D
,
Malik
 
S
,
Ballard-Hernandez
 
J
,
Motie
 
M
,
Liao
 
S.
 
Examining the effects of an outpatient palliative care consultation on symptom burden, depression, and quality of life in patients with symptomatic heart failure
.
J Card Fail
 
2012
;
18
:
894
899
.

58

Kernick
 
LA
,
Hogg
 
KJ
,
Millerick
 
Y
,
Murtagh
 
FEM
,
Djahit
 
A
,
Johnson
 
M.
 
Does advance care planning in addition to usual care reduce hospitalisation for patients with advanced heart failure: a systematic review and narrative synthesis
.
Palliat Med
 
2018
;
32
:
1539
1551
.

59

Sahlen
 
KG
,
Boman
 
K
,
Brannstrom
 
M.
 
A cost-effectiveness study of person-centered integrated heart failure and palliative home care: based on a randomized controlled trial
.
Palliat Med
 
2016
;
30
:
296
302
.

60

Metzger
 
M
,
Song
 
MK
,
Devane-Johnson
 
S.
 
LVAD patients' and surrogates' perspectives on SPIRIT-HF: an advance care planning discussion
.
Heart Lung
 
2016
;
45
:
305
310
.

61

Brush
 
S
,
Budge
 
D
,
Alharethi
 
R
,
McCormick
 
AJ
,
MacPherson
 
JE
,
Reid
 
BB
,
Ledford
 
ID
,
Smith
 
HK
,
Stoker
 
S
,
Clayson
 
SE
,
Doty
 
JR
,
Caine
 
WT
,
Drakos
 
S
,
Kfoury
 
AG.
 
End-of-life decision making and implementation in recipients of a destination left ventricular assist device
.
J Heart Lung Transplant
 
2010
;
29
:
1337
1341
.

62

Siouta
 
N
,
Clement
 
P
,
Aertgeerts
 
B
,
Van Beek
 
K
,
Menten
 
J.
 
Professionals' perceptions and current practices of integrated palliative care in chronic heart failure and chronic obstructive pulmonary disease: a qualitative study in Belgium
.
BMC Palliat Care
 
2018
;
17
:
103
.

63

Goldstein
 
NE
,
Mather
 
H
,
McKendrick
 
K
,
Gelfman
 
LP
,
Hutchinson
 
MD
,
Lampert
 
R
,
Lipman
 
HI
,
Matlock
 
DD
,
Strand
 
JJ
,
Swetz
 
KM
,
Kalman
 
J
,
Kutner
 
JS
,
Pinney
 
S
,
Morrison
 
RS.
 
Improving communication in heart failure patient care
.
J Am Coll Cardiol
 
2019
;
74
:
1682
1692
.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Supplementary data